[2025-09-25T11:33:49.876290] [QUERYOME] Starting research for query 146: 'Instructions: 
 Answer the question below. Please respond with the option letter (A, B, or C) first. (HINT: Each PubMedQA instance is composed of (1) a question which is either an existing research article title or derived from one, (2) a context which is the corresponding abstract without its conclusion, (3) a long answer, which is the conclusion of the abstract and, presumably, answers the research question, and (4) a yes/no/maybe answer which summarizes the conclusion.) 

Question:
Do adjuvant aromatase inhibitors increase the cardiovascular risk in postmenopausal women with early breast cancer? 

Options:
{'A': 'yes', 'B': 'no', 'C': 'maybe'}'
[2025-09-25T11:33:49.948726] [PI] Starting research for query: 'Instructions: 
 Answer the question below. Please respond with the option letter (A, B, or C) first. (HINT: Each PubMedQA instance is composed of (1) a question which is either an existing research article title or derived from one, (2) a context which is the corresponding abstract without its conclusion, (3) a long answer, which is the conclusion of the abstract and, presumably, answers the research question, and (4) a yes/no/maybe answer which summarizes the conclusion.) 

Question:
Do adjuvant aromatase inhibitors increase the cardiovascular risk in postmenopausal women with early breast cancer? 

Options:
{'A': 'yes', 'B': 'no', 'C': 'maybe'}'
[2025-09-25T11:33:49.950442] Saving text to bench_final/run1/pubmedqa/pubmedqa_145/pi_initial_prompt.txt
[2025-09-25T11:33:49.973644] [PI] Calling o3 for initial analysis...
[2025-09-25T11:34:08.496458] [PI] Reasoning iteration 1
[2025-09-25T11:34:08.499094] [PI reasoning] **Assessing cardiovascular risks**

I see that many trials indicate there's no significant difference overall, but there's an increase relative to tamoxifen. The ATAC trial shows similar cardiovascular events between anastrozole and tamoxifen, with slightly lower cerebrovascular events for anastrozole but no significant difference. The BIG 1-98 trial found more events with letrozole. A meta-analysis suggests AI therapy might carry a higher cardiovascular risk than tamoxifen. So, to answer the binary question, yes, there's an increased risk compared to tamoxifen. I'll want to explore relevant studies on PubMed.
[2025-09-25T11:34:08.501191] [PI] No function calls found in response
[2025-09-25T11:34:08.511073] [PI] No more function calls - research complete
[2025-09-25T11:34:08.513733] Saving text to bench_final/run1/pubmedqa/pubmedqa_145/pi_final_answer.txt
[2025-09-25T11:34:08.518989] [QUERYOME] Query completed successfully
